bms-536924 (e1abcf3e-9572-4577-8ec4-a176e4eb8799) (Collection)

Project:

Drugmonizome

Dcc Asset:

IDG C2M2 2024-01-09 datapackage validated.zip

Dcc:

IDG

Compound:

4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone

Collection:

e1abcf3e-9572-4577-8ec4-a176e4eb8799.json

Persistent Id:e1abcf3e-9572-4577-8ec4-a176e4eb8799.json

Description:Metadatata for bms-536924

Creation Time:2021-09-08T00:00:00

Linked to

	Label	Description
	e1abcf3e-9572-4577-8ec4-a176e4eb8799.json File (Entity type)	A file from IDG as part of the Drugmonizome project
	4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone Compound (Entity type)	nan

e1abcf3e-9572-4577-8ec4-a176e4eb8799.json

A file from IDG as part of the Drugmonizome project

4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone

nan

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.